MedPath

Evaluation the effect of pregabalin on succinylcholine fasciculation and myalgia

Phase 2
Conditions
fasciculation.
Fasciculation
Registration Number
IRCT20160430027677N11
Lead Sponsor
Oroumia University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
100
Inclusion Criteria

aged 20 to 60 years old
American Society of Anesthesiologists class I and II

Exclusion Criteria

Patients with BMI above 25 kg/m²
history of central nervous system disease
renal dysfunction
history of allergy to any of the drugs used during the study
history of peptic ulcer disease and antacid therapy
patients who used analgesic drug within 24 hours before surgery
used any kind of sedative drug
patients with a history of taking antidepressants and calcium channel blockers
patients who had contraindication for succinylcholine
patients whose laparoscopic cholecystectomy will be replaced with open cholecystectomy

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fasciculation. Timepoint: Immediately after injection of succinylcholine. Method of measurement: visual analog scale.
Secondary Outcome Measures
NameTimeMethod
Incidence of myalgia. Timepoint: 6, 12, 18, and 24 hours after surgery. Method of measurement: visual analog scale.;Severity of myalgia. Timepoint: 6, 12, 18, and 24 hours after surgery. Method of measurement: visual analog scale.
© Copyright 2025. All Rights Reserved by MedPath